Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lawrie

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Plos One|January 29, 2013
No evidence for cardiac dysfunction in Kif6 mutant miceAbdul Hameed, Ellen Bennett, Barbara Ciani, et al.
The American Journal of Pathology|December 25, 2007
Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertensionAllan Lawrie, Elizabeth Waterman, Mark Southwood, et al.
Experimental Physiology|December 20, 2016
Maintained right ventricular pressure overload induces ventricular-arterial decoupling in miceMario Boehm, Allan Lawrie, Jochen Wilhelm, et al.
Pulmonary Circulation|September 7, 2018
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX projectRito Bergemann, James Allsopp, Harvey Jenner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2003
Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleusJennifer M Sarjeant, Allan Lawrie, Caroline Kinnear, et al.
The European Respiratory Journal|June 8, 2023
TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertensionFu-Chiang Yeh, Chien-Nien Chen, Chong-Yang Xie, et al.
Pulmonary Circulation|July 9, 2024
Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertensionAllan Lawrie, Neil Hamilton, Steven Wood, et al.
Journal of Leukocyte Biology|May 13, 2011
TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammationEmmet E McGrath, Helen M Marriott, Allan Lawrie, et al.
The European Respiratory Journal|September 24, 2016
Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertensionPeter M Hickey, Alfred A R Thompson, Athanasios Charalampopoulos, et al.
Pulmonary Circulation|October 7, 2022
Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertensionAllan Lawrie, Neil Hamilton, Steven Wood, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Plos One|January 29, 2013
No evidence for cardiac dysfunction in Kif6 mutant miceAbdul Hameed, Ellen Bennett, Barbara Ciani, et al.
The American Journal of Pathology|December 25, 2007
Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertensionAllan Lawrie, Elizabeth Waterman, Mark Southwood, et al.
Experimental Physiology|December 20, 2016
Maintained right ventricular pressure overload induces ventricular-arterial decoupling in miceMario Boehm, Allan Lawrie, Jochen Wilhelm, et al.
Pulmonary Circulation|September 7, 2018
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX projectRito Bergemann, James Allsopp, Harvey Jenner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2003
Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleusJennifer M Sarjeant, Allan Lawrie, Caroline Kinnear, et al.
The European Respiratory Journal|June 8, 2023
TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertensionFu-Chiang Yeh, Chien-Nien Chen, Chong-Yang Xie, et al.
Pulmonary Circulation|July 9, 2024
Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertensionAllan Lawrie, Neil Hamilton, Steven Wood, et al.
Journal of Leukocyte Biology|May 13, 2011
TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammationEmmet E McGrath, Helen M Marriott, Allan Lawrie, et al.
The European Respiratory Journal|September 24, 2016
Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertensionPeter M Hickey, Alfred A R Thompson, Athanasios Charalampopoulos, et al.
Pulmonary Circulation|October 7, 2022
Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertensionAllan Lawrie, Neil Hamilton, Steven Wood, et al.
Pageof 14